For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Sanguinarine is an extract from Macleaya cordata.
Scope of the Report:
Macleaya cordata is a poisonous herb native to China and Japan. It is a perennial plant, with deep lobed leaves and dusty clouds of tiny blossom at the tips of erect stems, most often a white color. It contains several alkaloids. Sanguinarine and chelerythrine are the main components of it, which have wide fungicidal and strong insecticidal activity.
The worldwide market for Sanguinarine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Sanguinarine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Shaanxi Guanjie Technology
- Xi'an Lyphar Biotech
- Hunan MT Health
- Lisi (Xian) Bio-Tech
- Shaanxi Fuheng (FH) Biotechnology
- Xian Biof Bio-Technology
- Xian Kono Chem
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- 0.4
- 0.6
- Others
Market Segment by Applications, can be divided into
- Pharmaceutical Ingredients
- Cosmetics Ingredients
- Feed Additives
- Agricultural Insecticide
- Oral Care Products
There are 15 Chapters to deeply display the global Sanguinarine market.
Chapter 1, to describe Sanguinarine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sanguinarine, with sales, revenue, and price of Sanguinarine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sanguinarine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sanguinarine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sanguinarine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source